HCA Healthcare Inc (NYSE:HCA) Shares Sold by Oregon Public Employees Retirement Fund

Oregon Public Employees Retirement Fund cut its holdings in HCA Healthcare Inc (NYSE:HCA) by 5.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,506 shares of the company’s stock after selling 1,486 shares during the period. Oregon Public Employees Retirement Fund’s holdings in HCA Healthcare were worth $3,770,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Wealthfront Advisers LLC grew its holdings in shares of HCA Healthcare by 4.5% during the fourth quarter. Wealthfront Advisers LLC now owns 7,054 shares of the company’s stock worth $1,043,000 after purchasing an additional 305 shares during the last quarter. Alps Advisors Inc. purchased a new position in shares of HCA Healthcare during the third quarter worth about $352,000. National Pension Service grew its holdings in shares of HCA Healthcare by 4.7% during the third quarter. National Pension Service now owns 372,050 shares of the company’s stock worth $44,802,000 after purchasing an additional 16,709 shares during the last quarter. Penserra Capital Management LLC purchased a new position in shares of HCA Healthcare during the third quarter worth about $26,000. Finally, Huntington National Bank grew its holdings in shares of HCA Healthcare by 6.9% during the fourth quarter. Huntington National Bank now owns 5,727 shares of the company’s stock worth $846,000 after purchasing an additional 371 shares during the last quarter. Institutional investors own 69.54% of the company’s stock.

In other HCA Healthcare news, insider Michael S. Cuffe sold 5,891 shares of HCA Healthcare stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $147.04, for a total value of $866,212.64. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Kathleen M. Whalen sold 1,956 shares of HCA Healthcare stock in a transaction that occurred on Friday, February 7th. The shares were sold at an average price of $146.46, for a total value of $286,475.76. Following the completion of the sale, the senior vice president now directly owns 3,964 shares in the company, valued at approximately $580,567.44. The disclosure for this sale can be found here. In the last three months, insiders have sold 68,727 shares of company stock worth $10,018,829. Corporate insiders own 2.70% of the company’s stock.

Several equities analysts have issued reports on HCA shares. Barclays raised their price objective on HCA Healthcare from $172.00 to $177.00 and gave the stock a “positive” rating in a report on Monday, February 3rd. Bank of America raised HCA Healthcare from a “neutral” rating to a “buy” rating in a report on Friday, December 6th. SunTrust Banks reaffirmed a “buy” rating and set a $185.00 price objective on shares of HCA Healthcare in a report on Wednesday, January 29th. Robert W. Baird raised their price objective on HCA Healthcare from $160.00 to $180.00 and gave the stock an “outperform” rating in a report on Wednesday, January 29th. Finally, Deutsche Bank started coverage on HCA Healthcare in a report on Friday, January 3rd. They set a “buy” rating and a $140.00 price objective on the stock. Two equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. HCA Healthcare presently has an average rating of “Buy” and an average target price of $163.81.

Shares of NYSE HCA traded down $2.64 during midday trading on Friday, reaching $148.24. 51,149 shares of the company were exchanged, compared to its average volume of 1,515,313. HCA Healthcare Inc has a 1 year low of $110.31 and a 1 year high of $151.97. The stock has a fifty day simple moving average of $146.75 and a 200 day simple moving average of $134.29. The stock has a market cap of $51.00 billion, a P/E ratio of 14.70, a PEG ratio of 1.18 and a beta of 0.93.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, January 28th. The company reported $3.09 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $3.09. HCA Healthcare had a negative return on equity of 242.04% and a net margin of 6.83%. The firm had revenue of $13.52 billion for the quarter, compared to analyst estimates of $13.37 billion. During the same quarter last year, the company posted $3.01 earnings per share. The business’s revenue was up 10.2% on a year-over-year basis. As a group, equities research analysts predict that HCA Healthcare Inc will post 11.68 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Monday, March 2nd will be issued a dividend of $0.43 per share. The ex-dividend date is Friday, February 28th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 1.16%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.40. HCA Healthcare’s dividend payout ratio (DPR) is currently 15.24%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Recommended Story: Understanding the different types of bonds

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.